Illumina, Inc. (NASDAQ:ILMN) Files An 8-K Submission of Matters to a Vote of Security Holders

Illumina, Inc. (NASDAQ:ILMN) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07

Submission of Matters to a Vote of Security Holders.

Illumina, Inc.’s 2018 annual meeting of stockholders (the “Annual Meeting”) was held on May23, 2018, at which the company’s stockholders voted upon the following proposals:

1.	The election of Jay T. Flatley, John W. Thompson, and Gary S. Guthart to our Board of Directors to hold office for three years until the annual meeting of stockholders in the year 2021. This proposal was approved.

2.	The ratification of the appointment of Ernst& Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December30, 2018. This proposal was approved.

3.	On an advisory basis, approval of the compensation paid to the Company’s “named executive officers” as disclosed in the Company’s Proxy Statement for the Annual Meeting. This proposal was approved.

4.	On an advisory basis, approval of a stockholder proposal to elect each director annually. This proposal was approved.

According to the inspector of election, stockholders present in person or by proxy representing 134,407,248 shares of the Company’s common stock voted on the proposals presented as follows:

Proposal1

Votes regarding the election of three director nominees were:

For	Against	Abstain	BrokerNon-Votes
Jay T. Flatley	118,006,714	6,590,391	97,456	9,712,687
John W. Thompson	123,603,464	990,330	100,767	9,712,687
Gary S. Guthart	124,327,096	266,846	100,619	9,712,687

Proposal2

Votes regarding the ratification of the appointment of Ernst& Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December30, 2018, were:

For	Against	Abstain	BrokerNon-Votes
132,329,953	1,715,086	362,209	—

Proposal3

Votes regarding the approval, on an advisory basis, of the compensation paid to the Company’s “named executive officers” as disclosed in the Company’s Proxy Statement for the Annual Meeting were:

For	Against	Abstain	BrokerNon-Votes
121,277,362	3,103,229	313,970	9,712,687

Proposal4

Votes regarding the approval, on an advisory basis, of a stockholder proposal to elect each director annually

For	Against	Abstain	BrokerNon-Votes
105,458,531	18,862,414	373,616	9,712,687

About Illumina, Inc. (NASDAQ:ILMN)
Illumina, Inc. (Illumina) offers sequencing and array-based solutions for genetic analysis. The Company’s products and services serve customers in a range of markets, enabling the adoption of genomic solutions in research and clinical settings. The Company’s customers include genomic research centers, academic institutions, government laboratories and hospitals, as well as pharmaceutical, biotechnology, agrigenomics and commercial molecular diagnostic laboratories, and consumer genomics companies. It provides sample-to-answer solutions to its customers in various areas of translational and clinical genomics, such as reproductive and genetic health, and oncology. It provides reproductive-health solutions, including preimplantation genetic screening and diagnosis, noninvasive prenatal testing, and neonatal and genetic health testing. It also provides whole-genome sequencing, genotyping and NIPT services. It has operations in the United States, Europe, Asia-Pacific and other markets.